skip to primary navigationskip to content
 

PolyProx Therapeutics raises £3.4m seed financing to validate novel class of cancer drugs

last modified May 01, 2019 08:22 AM
A spin out of the Department of Pharmacology at the University of Cambridge, PolyProx Therapeutics is based on over a decade of research and intellectual property from founder Professor Laura Itzhaki’s laboratory...

A spin out of the Department of Pharmacology at the University of Cambridge, PolyProx Therapeutics is based on over a decade of research and intellectual property from founder Professor Laura Itzhaki’s laboratory working closely with co-founders Dr Albert Perez-Riba and Dr Pamela Rowling and with other members of the Itzhaki group.

PolyProx Therapeutics will develop a new class of drugs, called Polyproxin™ molecules, that are able to selectively target tumour cells and trigger the natural degradation machinery contained within the cell to arrest tumour growth.

Polyproxin™ molecules target disease-causing proteins within tumour cells and trigger pathways to eliminate these proteins, thereby halting further growth of the tumour.  This approach has the potential to address cancer targets that have proven untreatable using current technologies, important in major diseases such as lung, colorectal and pancreatic cancers. The technology behind this approach uses protein scaffolds to link a targeting entity at one end and a degradation trigger at the other, assembled in such a way as to allow access to the tumour cell and recyclable activity.

More details: www.polyprox.com and https://www.cambridgenetwork.co.uk/news/polyprox-therapeutics-3pt4mgbp-seed-financing-cancer-drugs/

« October 2019 »
October
MoTuWeThFrSaSu
123456
78910111213
14151617181920
21222324252627
28293031

RSS Feed Latest news

Pharmacology and Toxicology new link building

Oct 07, 2019

Some of the staff who will occupy the new areas were given a tour by SDC...

Annual David James Lecture

Sep 02, 2019

Title: Human Pain Channelopathies

Pharmacology Lunch-time Run Club

Aug 23, 2019

The Pharmacology Lunch-time Run Club has been going strong since September 2018! We would love to see new faces, so if anyone is interested please join us...

Study led by Gates Cambridge PhD Student Sampurna Chakrabarti

Aug 15, 2019

The group of Dr Ewan St. John Smith have demonstrated that the fluid which lubricates joints plays a key role in osteoarthritic pain...

View all news